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ABSTRACT
THE INCIDENCE OF EARLY STAGE POSTOPERATIVE NAUSEA AND
VOMITING FOLLOWING THE USE OF NITROUS OXIDE AND PROPHYLACTIC
ANTIEMETIC THERAPY: IMPLICATIONS FOR CLINICAL PRACTICE
by James Lanny Sullivan
December 2015
Nitrous oxide (N2O) is a volatile agent currently used during the induction and
maintenance of general anesthesia. Since its discovery in 1786 by Dr. Priestly, it is the
oldest volatile agent to find continued use in current practice (Kossick, 2014). In
conjunction with its extensive history, there is the debate regarding its emetic properties.
Numerous studies have investigated the effect of nitrous oxide to produce postoperative
nausea and vomiting (PONV) with varying and often conflicting results. Generally
speaking, nitrous oxide is theoretically an emetic and is believed to be associated with
PONV (Tramer, Moore, & McQuay, 1996). This has caused many providers to limit the
continued use of this agent in their anesthetic technique. The studies investigating this
association have been largely inconclusive but nonetheless have significantly influenced
the usage of nitrous oxide in current anesthesia practice. Furthermore, current standards
of practice promote the utilization of prophylactic antiemetic therapy to combat the
sustained incidence of PONV following anesthesia and surgery. Considering the current
standards regarding antiemetic therapy, evidence suggests that the combination with N2O
will decrease the incidence of PONV.
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CHAPTER I
INTRODUCTION
Development and Statement of Problem
Background
The incidence of postoperative nausea and vomiting (PONV) has a substantial
impact on healthcare facilities, providers, and patients. Occurrences of PONV result in
increased costs, utilization of resources, and decreased patient satisfaction (Kovac, 2013).
These factors are paramount to the surgical population due to the notable incidence of
PONV following anesthesia. PONV occurs with a general incidence of 25-30% in all
surgical patients, and ranges from 30% to 50% in the ambulatory surgery setting
(Golembiewski, Chernin, & Chopra, 2005; Kovac, 2013). This high prevalence has
resulted in many providers and associations focusing on methods to reduce the risk of,
and prevent the onset of PONV. This focus on risk reduction and prevention has had a
significant impact on nitrous oxide (N2O). Considered to have emetic properties, the
continued prevalence of a once highly utilized agent is now questionable among
anesthesia professionals.
Significance
Surviving innovation and technology, N2O is the oldest anesthetic agent still used
in current practice. Although it has an extensive record throughout the history of
anesthesia as being both safe and effective, its usage has seen a significant decline over
recent years. This decline has been validated by Yoshimura and Ushijima (2005), who
found a 48% decrease in the use of N2O from 97% in 1995 to 49% in 2004. Though
there are many possible reasons for this decline, it is closely associated to the perceived
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relationship between N2O and postoperative nausea and vomiting (PONV). The
significance of this relationship has been examined in numerous studies producing no
definitive conclusion, and often conflicting results. Though the results are ambiguous, in
a healthcare environment consumed with increased patient satisfaction and decreased
cost, this stigma surrounding N2O has caused many providers to abandon its use.
Problem Statement
Nitrous oxide is a safe, efficient, and valuable anesthetic agent offering
considerable benefit to current practice but is often underused due to its perceived
association with PONV. Due to the high prevalence of PONV following surgery and
general anesthesia, the current focus is engrossed in prevention and risk reduction rather
than treatment. This shift has resulted in the common practice of implementing
prophylactic antiemetic therapy during the surgical procedure with the expectation of
preventing the onset of PONV. In lieu of this new practice, the catechism then is whether
general anesthesia with N2O affects the incidence of PONV when the patient is treated
with prophylactic antiemetic therapy.
Theoretical Background
Theoretical Foundation
There are numerous theories and philosophies that drive healthcare practice.
They are helpful in creating a guideline for interpreting and understanding motivations
that influence daily routines and practice methods. Goodson (2011) proposes that
theories “lend meaning, provide explanation, impose order, and organize logically the
events that engulf healthcare professionals” (p. 78). Understanding and utilizing these
theories create the ability to implement new ideas and methodologies by healthcare
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professionals and healthcare systems in order to improve quality and outcomes. The
nursing philosophies and theories are important to this project due to the desire to
improve current practices and the overall healthcare environment. A requirement of the
Doctor of Nursing Practice (DNP) graduate is to influence positive change through
interventions that are congruent with the expectations and desires of those we care for.
These interventions are based on nursing theories that define the boundaries of nursing
actions, providing structure and unity that improve the continuity of care along with the
effectiveness of the interventions (Eldridge, 2011). Ultimately, nursing theory
establishes a holistic relationship between the provider and a patient encompassing the
values and beliefs of both, in order to achieve the greatest outcome.
Quality Improvement
In relation to nursing theories, this project is grounded on the Donabedian theory
of total quality management. Donabedian believed that quality could be defined and
influenced using three distinct concepts that are dependent upon each other for success:
structure, process, and outcomes (Donabedian, 1988; Edwardson, 2007). He believed
that these concepts are all affected by costs, expectations, and resource limitations,
encompassing both direct and indirect variables while focusing on the most beneficial
outcome (Anderson, 2011; Donabedian, 1988). Particularly significant is Donabedian’s
belief that quality management is a shared responsibility of the provider, consumer, and
community (Donabedian, 1988). In effect, Donabedian created a simplified model that
can be readily and easily adapted to almost any circumstance, and closely resembles
many of the proposed concepts of the new Affordable Care Act.
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The Donabedian theory was chosen as the foundation for this project due to its
relevance with the current healthcare environment and focus on quality improvement.
Donabedian insisted that his concepts of structure, process, and outcomes were critical to
quality management in order to find the most efficient and legitimate processes that will
provide the greatest benefit for the least cost to the patient (Anderson, 2011). Using these
concepts, he insisted that “good structure increases the likelihood of good process, and
good process increases the likelihood of a good outcome” (Donabedian, 1988, p. 1745).
In applying this model to the project, structure is represented by the qualifications and
knowledge basis of the providers, while process signifies the degree in which providers
conform to the standards of care and expectations of the facility and patients. The
objective, then, is to influence the structure and process in order to influence the
outcomes.
The continuous rise in healthcare costs has created the development of new
payment methods that are closely related to this project and chosen theory. Cost and
quality are synonymous in that lower quality and insufficiency coexist through wasteful
care. Donabedian (1988) stated that this is “directly harmful to health or is harmful by
displacing more useful care” and that “the practice of optimal care requires added
knowledge of costs, and also some method of weighing each added bit of expected
usefulness against is corresponding costs” (p. 1745). This has led to the recent creation
of quality-based payment methods such as value based purchasing and the bundled
payment initiative. Both of these payment methods base provider and facility
reimbursement on the perceived quality of care rather than quantity. The sole purpose of
this project is to decrease the cost of healthcare while improving the quality of care to the
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patient. Quality based payments highlight the significance of this project, serving to
provide quality care in an efficient manner by decreasing the incidence of PONV,
improving patient satisfaction, increasing the quality of care, and the added benefit of
decreasing costs to both the provider and consumer.
DNP Essentials
Scientific Underpinnings for Practice
Nursing uses numerous models, concepts, and theories to guide practice. They
provide methods for understanding healthcare problems while also influencing
interventions to alleviate these problems. These models and theories establish
frameworks for developing goals and boundaries that can be examined for effectiveness
(Eldridge, 2011). Of significance to this project is Peplau’s interpersonal model. This
model and project are fitting due to the sequential steps and underlying concepts that are
required to reach a goal. Peplau believed that the work of the nurse is fundamental to the
patient regaining health and well-being (Peplau, 1997). Together, the nurse and patient
work toward mutually agreed-upon goals by defining the problems, clarifying the
expectations, exploiting different practices, and developing a solution (Eldridge, 2011).
This model is utilized in the project by establishing PONV as the problem, identifying
efficiency and decreased PONV as the expectation, and by exploiting a different
anesthetic technique in order to reach the desired goal. Instituting this model establishes
the groundwork for this project to meet the expectations of both the patient and provider.
Organizational and Systems Leadership
A major focus of the DNP curriculum is the ongoing improvement of clinical
nursing practice, health outcomes, and patient safety. These goals are of considerable
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importance to the current healthcare environment that is consumed with the rising cost of
healthcare and maintaining patient satisfaction. In recognition of these factors,
Churchman’s systems model will be exploited in this project in an effort to attain these
goals. Churchman proposed the notion of considering an action without taking the
action, suggesting that the action could be evaluated to estimate its probability of
attaining a goal (Churchman, 1973). This assumption led to a model that divides a
system into five categories with the clients' interest representing the essence of the system
(Petersen, 2011). The categories consist of the client, environment, decision maker,
planner, and measure of performance. In relation to this project, the anesthesia providers
illustrate the planner while the healthcare structure characterizes the environment.
Applying this model, the planner seeks to improve the measure of performance in order
to satisfy mutual objectives of the decision maker and environment.
Clinical Scholarship
In healthcare and practice, proficiency and performance can never be improved
without scrutiny. Competency and advancement requires a willingness to challenge
traditional views and methods in order to stimulate new knowledge that is significant to
both healthcare and the profession (Tymkow, 2011). Pertinent to achieving new
knowledge and improving outcomes is the ability to evaluate current processes and to
translate research into practice. Employing these concepts inspires the implementation of
quality improvement initiatives and clinical practice guidelines that enhance healthcare
outcomes. This project ventures to execute these concepts by combining a traditional
method of anesthesia with current research to motivate evidence-based practice.
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Instituting this method, the goal then is that this project will result in a practice strategy
that improves provider productivity, anesthesia quality, and patient-centered outcomes.
Information Systems/Technology
Technology and information systems are growing at an exponential rate
throughout the healthcare field. With a presidential executive order mandating electronic
health records (EHR) in all healthcare systems, nursing informatics has become a top
priority in healthcare and education. Competency in nursing informatics has since been
addressed in the National League for Nursing’s position statement and in the Institute of
Medicine’s five quality and safety competencies (Burkart-Jayez, 2011; Institute of
Medicine, 2011; National League for Nursing, 2015). The informatics provide
significant benefit to both practice and research by preventing errors, aggregating data,
and providing better information to medical records. This project takes advantage of the
informatics produced in the EHR by using this system for outcomes management. The
applicable data is promptly recorded in the EHR and readily available. The data is then
capable of being gradually reviewed for outcome analysis. This method of data
collection, using the EHR, has the valuable effect of decreasing time consumption,
preventing numerous errors, and expediting results.
Objectives
Purpose and Objectives
The purpose of this project is to evaluate the incidence of PONV following the
administration of general anesthesia with N2O, when the patient is treated with
prophylactic antiemetic therapy. N2O is a safe, reliable, and efficient agent with a proven
record of clinical benefits. However, this agent does conceivably harbor emetic

8

properties. With PONV considered by patients as a highly displeasing side effect of
surgery, and costing hospital facilities thousands of dollars in lost revenue, N2O has lost
favorability among many providers. The primary objective then, is to determine the
clinical significance of N2O and antiemetic therapy on the incidence of PONV. If the
project is successful in determining no clinical correlation between these variables, the
secondary objective will be to increase provider knowledge in order to influence a change
in practice. This project will potentially result in improved patient satisfaction and
outcomes, which, in conforming to the new method of value based reimbursement, will
result in decreased cost and improved revenue for the provider and facility.
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CHAPTER II
REVIEW OF RELATED LITERATURE
Postoperative Nausea and Vomiting
Incidence and Significance
Postoperative nausea and vomiting is a common complication following surgery
and anesthesia. It is estimated to occur with a general incidence of 25-30% in all surgical
patients, with nausea occurring more frequently at 40-50% and vomiting at 25-30%
depending on the surgical population (Kovac, 2013). This incidence can increase
significantly with certain risk factors to a level of 70 to 80% (Fernandez-Guisasola,
Gomez-Arneu, Cabrera, & Garcia del Valle, 2010). These rates are significant to both
healthcare providers and institutions due to the numerous risks associated with this
complication. Uncontrolled and persistent PONV can lead to unanticipated hospital
admissions, electrolyte abnormalities and dehydration, tension on fresh suture lines,
hematomas beneath surgical flaps, and increased risk of pulmonary aspiration (Apfel et
al., 2012; Casey, 2013; Golembiewski et al., 2005). These complications contribute not
only to morbidity, but also affect patient satisfaction, delay patient discharge, and
increase hospital costs (Norred, 2003). In same day surgical centers, the annual cost of
PONV is estimated to be between $250,000 and $1,500,000 (Winston, Rinehart, Riley,
Vacchiano, & Pellegrini, 2003). This makes it increasingly important to identify the risks
that contribute to PONV.
Pathogenesis
The pathogenesis of postoperative nausea and vomiting is believed to be
multifactorial. The most common pathways believed to be associated with PONV are the
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chemoreceptor trigger zone (CTZ), the vomiting center, and the nucleus tractus solitarius
(NTS), incorporating complex central and peripheral receptors and numerous
neurotransmitters (Casey, 2013). The major neurotransmitters impacting these pathways
include dopamine, histamine, serotonin, and acetylcholine (Dahan, Niesters, Olofsen,
Smith, & Overdyk, 2013). These neurotransmitters exert their effects via receptors
located throughout the body. These receptors, essentially located in the pharynx, ear, gut,
and brain, are triggered by numerous stimuli including motion, over distention or stretch,
chemicals and toxins, emotions, smells, sights, or thoughts (Norred, 2003). Any of these
stimuli can then trigger the neural pathways to induce nausea and/or vomiting.
Contributing Risk Factors
Several risk factors have been identified to contribute to the incidence of
postoperative nausea and vomiting. According to a consensus guideline developed by
Gan et al. (2014), the strongest patient-specific predictor of PONV was female gender
followed by history of PONV, nonsmoking status, history of motion sickness, and age
greater than 50 years. There has been some evidence showing an increased incidence of
PONV due to anesthesia and surgery-related risk factors, including the use of volatile
anesthetics, intraoperative and postoperative use of opioids, and the type and duration of
surgical procedures (Gan, 2007). Using a randomized controlled trial of 1,180 patients,
Golembiewski et al. (2005) found that the strongest anesthesia-related risk factor for
postoperative vomiting was the use of volatile anesthetic agents “and was mostly
dependent on the duration of anesthesia, particularly in procedures lasting longer than
three hours” (p. 1255). This is in sharp contrast to Dahan et al. (2013) stating that
“although inhalation anesthetics contribute significantly to the problem, opioids are the
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major cause of PONV with an incidence of greater than 50% following balanced
anesthesia” (p. 518). Certain types of surgery also carry a greater risk of PONV with
Helmy (1999) showing an incidence ranging from 44-77% following laparoscopic
procedures. This is in agreement with other studies showing higher incidences of PONV
with specific procedures or anatomic areas.
Risk Assessment
Due to the evident impact of PONV on healthcare costs and patient satisfaction,
risk stratification is needed to better guide treatment and prevention. In relation to the
vast number of contributing factors, many risk factor models are cumbersome and timeconsuming for healthcare providers. To combat this problem, simplified risk tools have
been developed in order to increase the identification of patients at risk for experiencing
PONV. As noted by Kovac (2013), “one of the presently more popular scores for clinical
and research purposes has been the simplified PONV risk score of Apfel et al.” (p. 1526).
This is substantiated by the inclusion of this model in clinical guidelines such as the
Society for Ambulatory Anesthesiology (Gan et al., 2014). According to the American
Society of Perianesthesia Nursing (ASPAN) (2006), this risk factor identification tool is
supported by three validation studies and “provides better discrimination and calibration
for the prediction of PONV” (p. 234). This simplified risk identification tool identifies
four predictors of PONV: female gender, nonsmoking status, history of previous PONV
or motion sickness, and the use of postoperative opioids. Using the risks identified, the
incidence of PONV is then calculated based on the number of risk factors present. For
further clarification, PONV is classified into two distinct time frames: 0-6 hours (early
PONV) and 6-48 hours (late PONV) (Tramer, Moore, & McQuay, 1997). This
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classification is again corroborated by its inclusion into specific clinical guidelines
(ASPAN, 2006; Gan et al., 2014). The stratification of these risk factors and time frames
enhance the ability of the healthcare providers to prevent and treat postoperative nausea
and vomiting.
Nitrous Oxide
Safety and Efficiency
In contrast to its association with PONV, the numerous clinical benefits of nitrous
oxide maintain its considerable value in current anesthesia practice. According to
Billingham and Smith (2014) nitrous oxide improves all aspects of anesthesia by:
enhancing the quality, speed, and safety of the induction phase; augmenting the quality of
the maintenance phase; and expediting the recovery period by also reducing the
occurrence of chronic postoperative pain. All of this is accomplished with “minimal
adverse effects and while also reducing overall costs” (p. 275). This argument was
strengthened by Joshi (2013) in stating that “overall, N2O can improve the quality and
safety of general anesthesia as well as facilitate recovery with clinically insignificant
adverse effects” (p. 11). These qualities promote the continued use of N2O in current
anesthesia practice.
One of the beneficial effects of N2O supporting its continued use is its ability to
reduce anesthetic requirements. A review by Myles, Leslie, Silbert, Paech, and Peyton
(2004) declared, “the most notable advantage of N2O is that it allows a dose-reduction (in
the order of 30-60%) of other more expensive and (possibly) more toxic anesthetic
drugs” (p. 170). The extensive analgesic property of N2O also causes a significant
reduction in opioid requirements. When compared to narcotics, 20% nitrous oxide has
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been shown to produce pain relief equivalent to morphine without significant side effects
(General Anesthetics, 2013). A study by Parbrook in 1964 concluded that inhalation of
20-25% N2O produced analgesic potency equivalent to 10mg – 15mg of intramuscular
morphine (O’Sullivan & Benger, 2003; Parbrook, 1964). This response was further
established by Kariman et al. (2011) in a study showing no significant difference between
50% N2O and fentanyl (2g/kg) in relieving moderate to severe pain. These analgesic
properties are highly valuable to anesthesia providers.
Nitrous oxide has also been shown to significantly improve induction and
emergence of anesthesia when used in combination with other volatile anesthetic agents.
This property, known as the second-gas effect, is routinely employed for the rapid
induction of anesthesia in children. The simultaneous administration of volatile
anesthetics with N2O causes a greater uptake of the anesthetic agent in the alveoli and
arterial blood, resulting in a clinically significant acceleration of induction (Nagelhout,
2014). According to Ewart (2010), the addition of N2O is associated “with a less
problematic induction of anesthesia, with fewer adverse airway events and higher
probability of first time insertion of laryngeal mask” (p. 215). This phenomenon has
been shown to significantly accelerate the reduction of accompanying volatile anesthetics
during emergence of anesthesia, increasing the speed of emergence (Peyton et al., 2011).
This results in clinically significant operating room efficiency. These benefits make
nitrous oxide highly valuable in modern anesthesia.
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Nitrous Oxide and Postoperative Nausea and Vomiting
Mechanisms of Action and Contributing Factors
The most significant controversy to nitrous oxide is its theoretical emetic
potential. Nitrous oxide is believed to stimulate PONV through numerous mechanisms.
According to Tramer, Moore, and McQuay (1996) “the most likely mechanism was
gastrointestinal distension by manual ventilation and N2O transfer to the gastrointestinal
tract” as well as activation of “the medullary dopaminergic system and increases in
cerebrospinal opioid peptides” (p. 186). Other factors suggested to cause PONV include
changes in middle ear pressure and bowel distention from diffusion of N2O into closed
cavities (Golembiewski et al., 2005). It is also hypothesized that the incidence of PONV
following N2O exposure may be related to the dosage and duration. A study observing
137 women undergoing laparoscopic gynecologic surgery showed no significant
difference between women receiving an oxygen/air mixture versus 50% N2O, but there
was a 29% increase in the incidence of PONV when N2O was increased to 70%
(Mraovic, Simurina, Sonicki, Skitarelic, Gan, 2008). In regards to duration, a recent
literature review by Peyton and Wu (2014) found that “the risk ratio of PONV increases
approximately 20% per hour after the first 45 min of exposure to N2O” but duration of
less than one hour produces little effect on this incidence (p. 1137). However, the risk
increase from N2O duration may be irrelevant, as the surgical duration has been shown to
increase the risk of PONV by 60% for every 30-minute increase in time (Gan, 2007).
While these mechanisms suggest an association between N2O and PONV, they are
largely inconclusive.
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Conflicting Results
Numerous studies have failed to show a significant correlation between N2O and
PONV. Evaluating two systematic reviews and four randomized controlled trials
observing the relationship between N2O and PONV, Ewart (2010) concluded that this
association is only evident in patients with a high baseline risk. This conclusion is
supported by a meta-analysis from Fernandez-Guisasola et al. (2010) showing that
omitting nitrous oxide reduced PONV by 20% in high-risk groups but also showed that
the incidence of PONV was high in both groups (33% N2O vs. 27% no N2O). Another
study observing the effect of N2O on forty female patients undergoing laparoscopic
cholecystectomy, a procedure and population considered high risk, found no significant
difference between groups with and without nitrous oxide (Ture, Takil, Eti, & Gogus,
2007). Furthermore, Pandit, Malviya, and Lewis (1995) observed no difference in the
incidence and severity of PONV in children undergoing tonsillectomy and
adenoidectomy, another procedure and population considered high risk, when N2O was
eliminated during induction and maintenance of anesthesia. This implies that omitting
N2O to prevent PONV has no significant impact and thus should not impede its use in
current practice.
Postoperative Nausea and Vomiting Prophylaxis
Risk Reduction and Efficiency
There is strong evidence supporting the prophylactic use of antiemetic therapy to
prevent PONV. Dexamethasone and ondansetron, in combination or alone, have both
been shown to significantly reduce the risk of PONV and is now being used by many
anesthesia providers (Gupta et al., 2003; Golembiewski et al., 2005). This is supported
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by Norred (2003) showing only a 7% incidence of vomiting, following prophylactic
administration of ondansetron, in women undergoing laparoscopic surgery. The
incidence of PONV was further decreased to zero with multimodal management. Gan
(2007) sustains these findings with evidence concluding that the combination of
ondansetron and dexamethasone prevented PONV in 97% of patients in the first 2 hours
after extubation and 87% in the first 24 hours. Considering the higher cost of care to the
hospital and patient due to PONV, antiemetic prophylaxis may reduce overall PONVrelated costs (Pueyo, Lopez-Olaondo, Sanchez-Ledesma, Ortega, & Carrascosa, 2003).
As noted by Gan et al. (2014), “given that several antiemetics are now generic and
inexpensive, some experts suggest it may appropriate to give 1 or 2 antiemetics to all
patients” (p. 88).
Current Standards and Guidelines
With a general incidence of PONV at approximately 25-30%, and reaching as
high as 70-80% in certain populations, the overall impact on the healthcare system is
significant (Kovac, 2013). It is considered by many patients to be the most undesirable
symptom following surgery and “one of the most common reasons for poor patient
satisfaction rating in the postoperative period” (Gan, Sloan, Dear, El-Moalem, &
Lubarsky, 2001, p. 395). In a healthcare culture largely focused on patient satisfaction,
prevention of PONV has become a top priority for many anesthesia providers. Many
clinical guidelines now promote the prophylactic use of anti-emetic therapy, especially in
high-risk settings (ASPAN, 2006). Gan et al. (2014) points out that the goal of
prophylactic anti-emetic therapy is “to decrease the incidence of PONV and thus patientrelated distress and reduce health care costs” (p. 85). Though the Society for Ambulatory
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Anesthesia suggests prophylactic therapy for those at moderate risk, others suggest
prophylactic therapy should be utilized for all ambulatory surgical patients (Gan et al.,
2014; Joshi, 2013; Kovac, 2013). Given the overall efficiency of prophylactic therapy
and the ability to reduce healthcare cost while improving patient satisfaction, it would
seem prudent to institute this treatment as the standard of care.
Summary
Given the current evidence, it is hard to conclude the overall impact of nitrous
oxide on postoperative nausea and vomiting. This becomes even more obscure due to the
overwhelming usage of propofol as the standard induction agent for anesthesia. Joshi and
Cunningham (2013) note that “the use of propofol for induction of anesthesia and
antiemetic prophylaxis, which is the current standard of care, further negates the emetic
effects of N2O”, further suggesting relatively little impact on the incidence of PONV (p.
1264). The beneficial effects of N2O to clinical practice maintain its relevance in a
healthcare setting fascinated with patient satisfaction and cost efficiency. With
prophylactic antiemetic therapy as the standard of care, evidence supports that this, in
combination with N2O, would meet those goals while having no significant impact on the
incidence of PONV.

18

CHAPTER III
METHODOLOGY
Preliminary Procedures
Population and Design
The inclusion criteria for this project consist of English-speaking adults between
the ages of 18 and 65, presenting for surgery to the same day surgical unit. All subjects
must receive an anesthetic technique consisting of a volatile anesthetic agent
(sevoflurane, desflurane, or isoflurane) in combination with N2O, as the primary
anesthetic method, by either an Anesthesiologist or Certified Registered Nurse
Anesthetist (CRNA). Participants administered a regional anesthetic will be included, so
long as the regional technique is used specifically for postoperative pain control and used
in combination with the primary method described above. These subjects must also
receive either ondansetron (Zofran) or dexamethasone (Decadron), or a combination of
both, immediately prior to or during the surgical procedure. At this time, the study is only
concentrating on Early PONV, which is considered nausea and/or vomiting that occurs
within the first 2 hours after surgery. Late and Delayed PONV is a possibility for study
at a later date. Exclusion criteria will include any subject that does not receive either
antiemetic therapy, alone or in combination, prior to the anesthesia end time. All subjects
considered having inpatient status, prior to the procedure, are excluded. All subjects
requiring admission to the intensive care unit or mechanical ventilation following the
procedure are also excluded.
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Setting
The setting for this study is a 512-bed, Level II Trauma Center in the Southeast
United States. The time frame selected includes a 12-month period, beginning June 30th
of 2014 and concluding June 30th of 2015.
Design
Following approval from the Institutional Review Board (IRB) of the hospital
facility and university, this project will be carried out utilizing a retrospective chart
review. Subjects will be recruited by means of convenience sampling via the Electronic
Patient Information Center (EPIC) software at the designated facility, with a minimum
goal of 25 and maximum of 150. Potential study participants will be determined using
the EPIC software to identify subjects presenting for surgery, through the same day
surgical unit, during the time period allotted. At this level, the charts will then be
individually analyzed for satisfaction of the remaining inclusion/exclusion criteria.
Measurement Evaluation
Data Collection and Procedures
Only de-identified data will be collected for subjects meeting the population
criteria listed above. The data collected will include the PONV risk factors outlined in
the simplified PONV risk score system (Table 1) to include age, gender, and smoking
status, history of PONV or motion sickness, administration of postoperative opioids,
duration of anesthesia, and the type of surgery. Data collected for outcome measurement
will include the administration, timing, and dosage of a rescue antiemetic due to an
incidence or complaint of nausea and/or vomiting, as well as readmission to the hospital
within 24 hours following a surgical procedure due to a complaint of PONV.
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Table 1
Simplified PONV Risk Score System

Risk Factors

Points

1.

Female Gender

1

2.

Non Smokers

1

3.

History of PONV

1

4.

Postoperative Opioids

1

Sum

0-4

Note: Simplified PONV risk score system to predict the incidence of PONV.

Data Analysis
The design of this study uses the simplified PONV risk score system to stratify
subjects into low, medium, or high-risk categories based on their number of risk factors.
An incidence of PONV will be considered positive if a subject requires the administration
of a rescue antiemetic, due to a complaint or incidence of nausea and/or vomiting, within
the first 2 hours following surgery. The primary endpoint of this project evaluates the
incidence of PONV for each assigned risk category (study group) and compares that data
to the overall incidence of PONV, for the respective group (control group); low = 20%,
medium = 40%, high = >60% (Table 2). The significance between the study group and
control group will be determined using the two-sample t-test with a significance level of a
= 0.05. Data will be further stratified by examining the influence of surgical duration and
type of surgery on the incidence of PONV using the Chi-Square Test for Independence,
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with a significance level of a = 0.05, as secondary endpoints. Readmission to the hospital
within 24 hours following a surgical procedure, due to a complaint of nausea and/or
vomiting, will be collected as a tertiary endpoint for further risk and outcome
stratification. All data will be analyzed using QuickCalcs software from GraphPad
Software, Incorporated.
Table 2
Incidence of PONV by Risk Category

Risk Category

Incidence of PONV

Low = 0-1 Risk Factors

< 20%

Moderate = 2 Risk Factors

40%

High = 3-4 Risk Factors

> 60%

Note: The average incidence of PONV based on the overall number of risk.

Ethical Protection
All information and data will be de-identified throughout the process of this
project. All antiemetic therapies and anesthetic agents reviewed in this study are proven,
safe, and accepted current practices in the field of anesthesia. The data analysis of this
proposed retrospective chart review occurs following surgical and anesthetic events, as
well as post hospital discharge, thus posing no risks to participants. Anesthesiologist and
Certified Registered Nurse Anesthetist’s (CRNA) have extensive knowledge and training
in the administration and monitoring of all medications and techniques involved.
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CHAPTER IV
ANALYSIS OF DATA
Responsiveness and Effect Size
Inclusion Criteria and Data Extraction
This study was designed as a retrospective chart review to evaluate the incidence
of early stage postoperative nausea and vomiting. Study subjects were recruited utilizing
EPIC software after receiving approval from the institutional ethics committee of the
medical center and university. Initial investigation identified 2,122 subjects that
presented to the same-day surgical unit for elective procedures between the dates of June
30th of 2014 to June 30th of 2015. Each chart was then individually analyzed for the
correct criteria. Of the 2,122 initial subjects, only 151 met the correct anesthetic and
antiemetic requirements.
A total of 95 subjects, meeting all of the inclusion criteria, were enrolled in the
study. All subjects received a general anesthetic in combination with nitrous oxide as
well as a prophylactic antiemetic treatment of ondansetron and/or dexamethasone, either
during or immediately prior to the procedure. Data collection included all factors known
to be associated with the risk of developing PONV as identified by the Apfel simplified
PONV risk score system (Apfel et al., 1999). Also recorded were the duration of
anesthesia and type of procedure, as these have been shown to influence the development
of PONV. The incidence of PONV was evaluated by recording the administration,
dosage, and timing of any antiemetic given during the first two hours (0-2h) of the
postoperative period. There was no incidence of readmission recorded for this population
during the time period of this study.
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Statistical Analysis
Primary Emetic Outcome
The patient demographics were evenly distributed for this study. The average age
of the study participants was 47 years, with males making up the majority at 53%. Most
of the subjects were non-smokers (73%), and only 2% had a history of PONV or motion
sickness. The main focus of this study is to evaluate the incidence of PONV following
the use of general anesthesia with nitrous oxide when the patient has been treated with
prophylactic antiemetics. The goal is to determine if the use of nitrous oxide has any
significant impact on the incidence of PONV when the patient has been treated with
prophylactic antiemetic therapy, as this has become the current standard of care. Due to
the limited size of the study, the differences between means were analyzed using the onesample t-test and a 95% confidence interval. Overall, the subjects in this population were
found to have less PONV than the general surgical population, 20% compared to 30%,
with a mean difference of 10% (95% CI: -0.181 to -0.018, P=0.0172). These findings
were then compared to a study by Koivuranta et al. (1997), measuring the incidence of
PONV following general anesthesia with nitrous oxide, using the two-sample z-test and a
95% confidence interval. Again, the study population experienced less PONV, with a
mean difference of 11% (95% CI: 0.014 to 0.206, P=0.025). Based on both comparisons,
these findings suggest that nitrous oxide has little to no effect on PONV when the patient
is treated with prophylactic therapy.
Simplified PONV Risk Score
For further stratification, the subjects of the study were distributed into one of
three groups based on the number of risk(s) identified using the simplified PONV risk
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score system: low (0-1), moderate (2), high (3-4). The moderate risk category was
largest with 53% of the population, followed by the high risk category at 26%, and the
low risk category at 21%. The incidences of PONV in these categories were compared to
the average incidence of PONV of their respective category as established by Apfel et al.
(1999) using the one-sample t-test and a 95% confidence interval. The low risk category
population of this study showed no real difference in the incidence of PONV, 15%
compared to 10-20% in the general population (95% CI: -0.221 to 0.121, P=0.549).
These statistics changed significantly however with the moderate and high risk category.
The incidence of PONV in the moderate risk population of this study was 18% lower
(95% CI: -0.299 to -0.061, P=0.0038) than its counterpart, with an incidence rate of 22%
compared to 40%. This was seen again in the high risk population of this study, with a
difference of -40% (95% CI: -0.568 to -0.232, P=0.0001) for a PONV incidence of 20%
compared to 60%.
For further diligence and sake of completeness, these populations were also
compared to their respective categories from a study by Koivuranta et al. (1997) using the
two-sample z-test and a 95% confidence interval. The low and moderate risk populations
of these two studies had little variation, with a difference of 9.5% (95% CI: -0.102 to
0.291, P=0.344) and 7.5% (95% CI: -0.061 to 0.211, P=0.283) respectively. As
previously seen, this changes with the high risk category. The incidence of PONV in the
high risk population of this study is considerably lower than the respective population of
the corresponding study, 20% versus 56%, with a cumulative difference of -36% (95%
CI: 0.161 to 0.56, P=0.0004).
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In evaluating these results, the evidence further suggests that nitrous oxide has minimal,
if any, effect on PONV when the patient has been treated with prophylactic antiemetics.
After initially analyzing the data, the decision was made to evaluate the impact of
nitrous oxide on the incidence of PONV between the three risk categories. Using the
two-sample t-test with a 95% confidence interval, the moderate and high risk populations
were individually compared to the low risk population since this category is known to
have the lowest incidence of PONV. Remarkably, there was no compelling difference in
the rate of PONV between the moderate or high risk populations when compared to the
subjects of the low risk category. The low versus moderate risk populations had a
disparity of only 7% (95% CI: -0.284 to 0.144, P=0.516), while the low versus high risk
population was only 5% (95% CI: -0.286 to 0.186, P=0.671). Though these samples are
small, the evidence again depreciates the hypothetical impact of nitrous oxide on the
incidence of PONV.
Gender Variability
The gender of the subjects in this population was recorded in order to evaluate
this correlation to the results, since the female gender has been concluded to be the
overall strongest predictor of PONV (Apfel et al., 2012). The female gender constituted
47% of the overall population with a PONV rate of 20% compared to the male gender at
53% and a PONV rate also equal to 20%. Interestingly, although the subject population
and incidence rate were nearly equal, men contributed to 95% of the subjects in the low
risk category, while women comprised 96% of the subjects in the high risk category. The
impact of gender on the incidence rate of PONV was evaluated using the fisher’s exact
test and chi-square test for independence. In utilizing both methods, it was determined
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that gender had no contributable influence on the incidence rate (p=1.0, x2=0, df=1).
With a relative risk of 1, it is concluded for this study that gender had no measurable
influence on the occurrence of PONV.
Procedure Effect
The type and duration of surgical procedures have recently been implicated as risk
factors for nausea and vomiting in the postoperative period. Predictive risk score models
containing these new factors have even been developed and published in recent years
(Smith, Smith, & Smith, 2012). The relationship of these variables on the incidence of
PONV was evaluated separately using the fisher’s exact test and chi-square test for
independence. Surgical duration was categorized into two groups: procedures lasting 60
minutes or less, and procedures lasting greater than 60 minutes with a population
distribution of 11% and 89% respectively. Postoperative nausea and vomiting differed
only slightly between the groups, with an incidence rate of 10% in the first group and
21% in the latter. This equates to a relative risk of 2.12, meaning that for a procedure
lasting longer than 60 minutes there is 112% more risk of PONV. Contrary to the
findings, testing in this study revealed no definitive relationship between the duration of
the procedure and PONV (P=0.68, x2=0.175, df=1).
Findings for the type of procedure differed slightly from the duration. Surgical
procedures were grouped into two categories for this study, abdominal/gynecological and
neuro/ortho/vascular, since abdominal and gynecological procedures have shown to be
strongly related to PONV (Apfel et al., 2012). Abdominal procedures composed only
33% of the population, but had a PONV rate of 32% compared to 14% for all other
procedures. This alone established a relative risk of 2.29 and a 129% increase in risk for
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PONV. The fisher’s exact test could not definitively rebuke a relationship between these
variables (P=0.055). This is seen again with the chi-square test for independence
(x2=3.259, df=1, P=0.071), showing a weak relationship between the variables. Though
this evidence is not completely conclusive, it is reasonable to believe that there is a
relationship between the type of procedure and incidence of PONV.
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CHAPTER V
SUMMARY
Discussion of Results and Limitations
The evidence presented supports this study’s hypothesis that nitrous oxide has
little to no effect on the incidence of PONV when the patient has been treated with
prophylactic antiemetics. The overall incidence of PONV in this population was 20%
compared to the average of 30%. The incidence rate for this population was also lower
for every risk category of the simplified PONV risk score system. This was especially
apparent in the moderate and high-risk populations, in which this study produced a
difference of -20% and -40% respectively, from the general population. The results
could even be slightly skewed since a positive incidence of PONV was captured as an
administration of an antiemetic in the first two hours of the postoperative period. The
general postoperative orders stated to use ondansetron (Zofran) as the first line treatment
for PONV, but it was found in this study that promethazine (Phenergan) was given first in
seven of the nineteen positive cases. This may have been due to preference given the
known anxiolytic and sedative effects of this drug. Also, other factors suspected of
influencing the incidence of PONV, such as the administration of intraoperative opioids,
were not included. For the purpose of this study, only risk factors that have been proven
and validated as strong predictors of PONV were included. Although there are
limitations to this study, due to the small sample size and retrospective technique, it can
be reasonably speculated that the results will be similar in a larger population.
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Conclusion
Implications for Theory and Practice
With the current standard of using propofol for the induction of anesthesia and
prophylactic coverage of antiemetics, there is no evidence to support the omission of
nitrous oxide. Propofol reduces the risk of PONV by 19% along with a 25% reduction by
ondansetron and dexamethasone each, while omitting nitrous oxide only reduces the risk
by 12% (Smith, Smith, & Smith, 2012). As presented here, these variables sustained a
substantially lower incidence of PONV than the general surgical population.
Determining the significance of nitrous oxide on PONV, in regards to the variables of
this study, would require a truly randomized controlled trial in which all subjects received
exactly the same anesthetic and prophylactic treatment. This will be considerably easier
in the near future as, following this study, the EPIC system at the host facility will be
initiating a search function in January of 2016 to aid in the retrieval of specific data and
variables. Features such as this notably increase the efficiency of initiating, evaluating,
and disseminating critical information pertinent to the pursuit of improved performance
and education.
Future Direction
The continued, and increased use of nitrous oxide in current practice is supported
by the evidence presented in this study. This agent has a proven track record in the field
of anesthesia, and has been tested repeatedly over the decades. It is the only general
anesthetic that provides analgesic properties while reducing opioid requirements and
dosages of other, more expensive volatile anesthetics (Myles et al., 2004).
Complementary of its second-gas effect, it greatly reduces the induction and emergence
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of anesthesia resulting in improved clinical efficiency (Nagelhout, 2014; Peyton et al.,
2011). This establishes the potential to create a practice strategy that improves provider
productivity, anesthesia quality, and patient-centered outcomes that will minimize
expenditures resulting in decreased cost and improved revenue for the provider and
facility. This is highly valuable to the modern clinical setting, which is encompassed
with decreasing cost and utilization of resources. To gain a complete understanding of
the clinical impact, future studies should incorporate a cost analysis of this technique in
order to confirm the patient-specific and economical benefits. In conclusion, nitrous
oxide has been, and remains, an efficient and safe anesthetic that will continue to provide
positive results in current practice.
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APPENDIX C
LOW RISK CATEGORY

Gender

Age

Smoking
Status

Hx of PONV/
Motion Sickness

Duration
(min)

Opioids + PONV

Male

65

Yes

No

109

No

No

Male

60

Yes

No

95

No

No

Male

40

No

No

170

No

Yes

Male

33

Yes

No

227

Yes

No

Male

25

No

No

62

No

No

Male

35

Yes

No

100

Yes

Yes

Female

65

Yes

No

124

No

No

Male

20

Yes

No

138

Yes

No

Male

54

Yes

No

180

Yes

No

Male

65

No

No

78

No

No

Male

36

Yes

No

81

Yes

No

Male

28

No

No

78

No

No

Male

55

No

No

136

No

No

Male

30

Yes

No

62

Yes

No

Male

60

No

No

64

No

No

Male

38

Yes

No

157

Yes

No

Male

20

No

No

135

No

No

Male

20

Yes

No

178

Yes

No

Male

53

Yes

No

43

Yes

No

Male

38

Yes

No

213

Yes

No
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APPENDIX D
MODERATE RISK CATEGORY

Gender

Age

Smoking
Status

Hx of PONV/
Motion Sickness

Duration
(min)

Opioids + PONV

Female

64

No

No

68

No

No

Male

52

No

No

183

Yes

No

Male

66

No

No

192

Yes

Yes

Male

19

No

No

94

Yes

Yes

Male

62

No

No

239

Yes

No

Male

65

No

No

75

Yes

No

Female

29

Yes

No

120

Yes

No

Female

30

Yes

No

82

Yes

Yes

Male

61

No

No

278

Yes

No

Female

61

Yes

No

125

Yes

No

Male

18

No

No

55

Yes

No

Male

51

No

No

477

Yes

Yes

Female

61

No

No

100

No

No

Female

58

Yes

No

203

Yes

No

Female

64

No

No

91

No

No

Female

56

Yes

No

111

Yes

Yes

Male

45

No

No

213

Yes

Yes

Male

54

No

No

126

Yes

No

Female

56

Yes

No

112

Yes

No

Male

58

No

No

152

Yes

No

Female

61

No

No

76

No

No

Female

65

No

No

117

No

No

Male

59

No

No

238

Yes

Yes

Female

49

Yes

No

40

Yes

No
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Gender

Age

Smoking
Status

Hx of PONV/
Motion Sickness

Duration
(min)

Opioids + PONV

Male
Male
Female
Male
Female
Male

65
64
53
59
26
47

No
No
Yes
No
Yes
No

No
No
No
No
No
No

165
160
80
139
52
103

Yes
Yes
Yes
Yes
Yes
Yes

No
Yes
Yes
No
No
No

Male
Female
Male
Female
Male
Male
Male
Male
Male

55
40
39
54
64
64
38
65
63

No
No
No
Yes
No
No
No
No
No

No
No
No
No
No
No
No
No
No

135
67
130
91
128
62
198
55
64

Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
Yes
No
No

Male
Female
Female
Male
Male
Female
Female
Male
Male
Male
Male

32
50
38
53
39
37
40
46
48
62
65

No
Yes
No
No
No
No
Yes
No
No
No
No

No
No
No
No
No
No
No
No
No
No
No

204
130
155
190
59
75
84
160
134
43
142

Yes
Yes
No
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
Yes
No
No
No
No
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APPENDIX E
HIGH RISK CATEGORY

Gender

Age

Smoking
Status

Hx of PONV/
Motion Sickness

Duration
(min)

Opioids + PONV

Female

55

Yes

Yes

53

Yes

Yes

Female

19

No

No

282

Yes

Yes

Female

58

No

No

70

Yes

No

Female

43

No

No

98

Yes

No

Female

29

No

No

54

Yes

No

Female

29

No

No

65

Yes

No

Female

19

No

No

60

Yes

No

Female

35

No

No

120

Yes

No

Female

63

No

No

144

Yes

No

Female

60

No

No

68

Yes

No

Female

63

No

No

129

Yes

No

Female

53

No

No

155

Yes

No

Female

46

No

No

76

Yes

Yes

Female

46

No

No

72

Yes

No

Female

57

No

No

86

Yes

No

Female

21

No

No

65

Yes

Yes

Female

62

No

No

126

Yes

No

Female

38

No

No

121

Yes

No

Female

28

No

No

69

Yes

Yes

Female

51

No

No

64

Yes

No

Female

64

No

No

118

Yes

No

Female

64

No

No

138

Yes

No

Female

32

No

No

84

Yes

No

Male

24

No

No

76

Yes

No

Female

29

No

Yes

140

Yes

No
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APPENDIX F
LITERATURE REVIEW TABLE
HISTORY

Author &
Date

Objective

Design & Sample

Findings

Apfel et al.
(1999)

Risk validation
& simplification

Logistic regression
of 2,722 patients

Risk scores
predict PONV

Casey
(2013)

Continuing
development

Review article

Universal
emetic therapy

Dahan et al.
(2013)

Clinical
education

Textbook

Fernandez et al.
(2010)

Association of
N2O & PONV

Systematic review
of 4,598 patients

N2O has little
impact on
PONV

Gan et al.
(2001)

Cost-benefit
analysis of PONV

Questionnaire of
80 patients

Patients will
pay $56-$100
for effective
antiemetic

Golembrewski et al.
(2005)

Determining risk
for PONV

Clinical review

Prophylactic
antiemetic
therapy is
effective

Koivuranta et al.
(1997)

Estimate the
incidence of PONV

Survey of 1,107
patients

Anti-emetics
given to 31%
of patients

Kovac
(2013)

Managing PONV

Review article

Prophylaxis
for moderate
risk or higher

Norred
(2003)

Antiemetic
prophylaxis

Review article

Multimodal
approach
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Author &
Date

Objective

Design & Sample

Findings

Winston et al.
(2003)

Efficacy of 70%
isopropyl alcohol
and ondansetron

Randomized trial
of 100 healthy
women

PONV treated
faster with
alcohol than
ondansetron

Yoshimura &
Ushijima
(2005)

Determine N2O
consumption

Retrospective
review

Use of N2O
has decreased
significantly
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APPENDIX G
LITERATURE REVIEW TABLE
CONFLICTING DATA

Author &
Date

Objective

Design & Sample

Findings

Apfel et al.
(2012)

Risk factors to
predict PONV

Systematic
review

Independent
predictors of
PONV

Gan
(2007)

Management of
PONV

Clinical
guideline

Reduce base
line risk
factors

Gan et al.
(2014)

Management of
PONV

Clinical
guideline

Prophylaxis
for moderate
to high risk
patients

Helmy
(1999)

Prophylactic
efficacy of
ondansetron

Randomised,
double-blind
comparison in
160 patients

Incidence of
PONV is
lower with
ondansetron

Mraovic et al.
(2008)

Dose response
of N2O

Randomized,
controlled trial
of 137 patients

N2O may
increase
PONV in dose
dependent
fashion

Pandit et al.
(1995)

Role of N2O on
PONV in children

Randomized trial
of 60 children
undergoing
tonsillectomy

No significant
difference
with or
without N2O

Peyton & Wu
(2014)

Effect of
duration of N2O

Systematic review
with regression of
risk ratio in 10,317
patients

No significant
risk of PONV
under an hour
of exposure
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Author &
Date

Objective

Design & Sample

Findings

Smith et al.
(2012)

Management of
PONV

Review article

No uniform
standardized
approach for
managing
PONV

Tramer et al.
(1996)

Effectiveness
& safety of
omitting N2O

Meta-analysis
of 24 randomized
controlled trials

N2O had no
effect on
PONV

Ture et al.
(2007)

Effect of N2O
on PONV

Randomized
controlled trial
of 40 females

N2O had no
influence on
PONV
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APPENDIX H
LITERATURE REVIEW TABLE
INTERVENTIONS AND IMPLICATIONS

Author &
Date

Objective

Design & Sample

Findings

ASPAN
(2006)

Prevention &
management of
PONV

Clinical practice
guideline

Initiate PONV
prophylaxis
as needed

Billingham &
Smith
(2014)

Role of N2O in
ambulatory
anesthesia

Review article

N2O remains
a valuable
agent

Ewart
(2010)

Effect of N2O
on PONV

Literature
review

No definitive
conclusion

Gupta et al.
(2003)

Affect of
prophylactic
antiemetics on
PONV

Systematic review
of randomized
controlled trials

Treatment
significantly
reduces
PONV

Joshi
(2013)

Optimizing
perioperative care
for rapid recovery

Review article

No convincing
reason to
avoid N2O

Joshi &
Cunningham
(2013)

Clinical
education

Textbook

Kariman et al.
(2011)

Effectiveness of
N2O in relieving
pain

Randomized trial
of 100 patients

No difference
between N2O
and fentanyl in
relieving pain

Myles et al.
(2004)

Risks and benefits
of N2O

Review article

Conclusive
data is lacking
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Author &
Date

Objective

Design & Sample

Findings

Nagelhout
(2014)

Clinical
education

Textbook

O' Sullivan &
Benger
(2003)

Capabilities for
emergency
medicine

Review article

Versatile and
effective as an
analgesic
agent

Parbrook et al.
(1964)

Potency of N2O
compared to
morphine

Vital capacity was
compared for N2O
and morphine to
measure pain relief

Improvement
in vital
capacity and
peak flow was
better w/ N2O

Peyton et al.
(2011)

Second gas effect
on emergence
from anesthesia

Randomized trial
of 20 patients
undergoing
surgery

Elimination of
N2O increases
the speed of
emergence

Pueyo et al.
(2003)

Cost-effectiveness
of antiemetics in
preventing PONV

Prospective
double-blind
study of ninety
females

Greater
satisfaction w/
prophylactic
antiemetics

Tramer et al.
(1997)

Comparison of
prophylactic
antiemetic efficacy

Meta-analytic
comparison of 3
different methods

N2O with
propofol
reduces the
risk of
awareness and
decreased cost
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APPENDIX I
LITERATURE REVIEW TABLE
THEORETICAL FOUNDATION

Author &
Date

Objective

Design & Sample

Findings

Anderson
(2011)

Theoretical
approach to quality
improvement

Textbook

Quality is
driven by
leaders

Burkart-Jayez
(2011)

Utilize information Textbook
systems to
transform healthcare

Balance
innovation to
improve care

Churchman
(1973)

Using a systems
design for
improvement

Working paper

Improvement
is achieved
through
planning and
reflection

Donabedian
(1988)

Assessing the
quality of care

Review article

To assess
quality one
must have
evaluate the
structure and
process

Edwardson
(2007)

Review of
conceptual
frameworks used
in research

Review of 49
different studies

Frameworks
especially
useful to nurse
investigations

Eldridge
(2011)

Scientific
underpinnings for
practice

Textbook

Every nurse
operates from
philosophical
and theoretical
base

Goodson
(2011)

What is theory
and what does it do

Textbook

Predict
behavior
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Author &
Date

Objective

Design & Sample

Findings

Institute of Medicine
(2011)

Recommendations
for the future of
of nursing

White Paper

Policy change
to promote
future
generations

National League
for Nursing
(2015)

Recommendations
for the faculty role
in preparing
students for
technology

Position
Statement

Increasing
education of
informatics

Peplau
(1997)

Understanding the
relationship b/w
client and nurse

Review article

Interaction
between two
individuals
with a
common goal

Peterson
(2011)

Transforming the
healthcare system

Textbook

Systems
thinking to
optimize
results for
maximum
results

Tymkow
(2011)

Understanding
clinical scholarship

Textbook

Intellectual
process of
developing
new
knowledge
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APPENDIX J
DNP ESSENTIALS

DNP Essential

Capstone Relation

I.

Scientific underpinnings for practice

This project utilizes Peplau's theory of
interpersonal relations in order to reach a
mutual goal by defining the problem,
clarifying the expectations, and exploiting
a different practice technique to develop
a solution.

II.

Organizational and systems
leadership for quality improvement
and systems thinking

Donabedian's simplified systems model for
total quality management was utilized in this
project in an attempt to improve quality
outcomes in the most efficient manner
possible. This was done by improving both
the structure and process, thereby improving
the outcome

III.

Clinical leadership and analytical
methods for evidence-based
practice

In order to evaluate the significance of this
project, the results were compared to the
national average using numerous statistical
methods and showed tremendously better
outcomes.

IV. Information systems/technology and
patient care technology for the
improvement and transformation of
health care

The EPIC software system was used in this
project for data collection and as a result,
new updates will be added to the system in
January of 2016 to improve data extraction
and information management.

V.

Annual trips were made to both the
national and state capital buildings to attend
meetings regarding healthcare policy and
access to care. This author personally
contacted and discussed national drug
shortages with U.S. Senators to provide
insight and recommendations.

Health care policy for advocacy in
health care
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DNP Essentials

Capstone Relation

VI. Interpersonal collaboration for
improving patient and population
health outcomes

This project was developed and
implemented only through the help and
collaboration of mentors and peers.
Following conclusion of this project, results
will be presented at the monthly anesthesia
conference at Keesler AFB.

VII. Clinical prevention and population
health for improving the nations
health

Development of this project stemmed from
the overwhelming incidence of PONV
following surgery and anesthesia. The
results of this project show significant
promise for improving surgical outcomes
and expectations while decreasing overall
costs.

VIII. Advance nursing practice

The sole purpose of this project was to
improve patient satisfaction and outcomes
while also meeting fiscal and provider
expectations. Utilization of nitrous oxide
with a decreased incidence of PONV can
significantly improve anesthesia and
surgical outcomes while greatly reducing
costs and utilization of resources.
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APPENDIX K
PROJECTED TIMELINE

Requirement

Start

Complete

Dependent

Topic &
Literature
Review

Jan. 14, 2014

Apr. 3, 2015

Approval from
Committee chair

Citi Training

Jan. 14, 2014

Feb. 2, 2014

Preliminary
Proposal

Oct. 13, 2014

Apr. 5, 2015

Approval from
Committee chair

Submit the
Graduate
Committee request
form

Oct. 13, 2014

Oct. 15, 2014

Approval from
Graduate school and
committee members

Contact
Graduate Reader

Oct. 15, 2014

Oct. 18, 2014

Approval from
Graduate reviewer

Submit final
outline of
Capstone

Apr. 5, 2015

Apr. 18, 2015

Completion of
literature review and
committee chair
approval

Capstone draft
submission to
committee

Apr. 13, 2015

Apr. 19, 2015

Completion of
literature review and
committee chair
approval

Proposal Defense
Meeting

Apr. 23, 2015

May 3, 2015

Committee approval
of final outline and
draft

Prospectus from
May 3, 2015
submitted to auditor

May 8, 2015

Successful defense of
capstone proposal

Submit title page
for approval

May 12, 2015

Committee approval
of proposal defense

May 9, 2015
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Requirement

Start

Complete

Dependent

IRB submissions
& approvals

May 28, 2015

July 27, 2015

Exemption approval
from FGH and USM
IRB committee's

Implementation
of project

July 28, 2015

Sept. 3, 2015

Extraction, collection
and analysis of all
relevant data to the
project

Oral Defense of
Capstone project

Sept. 22, 2015

Sept. 25, 2015

Submission and
committee approval
of final capstone
draft

Submit results
of oral defense
to graduate
auditor

Sept. 25, 2015

Sept. 28, 2015

Successful defense
and approval of
capstone project

Submit capstone
project to reviewer
for proofing and
approval

Sept. 28, 2015

Oct. 5, 2015

Successful oral
defense of capstone
project

Submit two final
Sept. 28, 2015
signed title pages
to graduate reviewer

Oct. 5, 2015

Successful oral
defense and approval
of capstone project

Oct. 5, 2015

Oct. 12, 2015

Completion of final
revision and graduate
reviewer approval

Oct. 16, 2015

Oct. 20, 2015

Completion of exam

Submit final
reviewer approved
copies of capstone
project
Comprehensive
exam results
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